The Division of Allergy, Immunology, and Transplantation (DAIT) explores how the immune system maintains health and, under abnormal conditions, also contributes to disorders. DAIT supports basic and clinical research to improve our understanding of the causes of immunologic diseases and to develop better diagnostic, treatment, and prevention strategies.
Daniel Rotrosen, M.D.
What's New:
-
Antibody Protects Against Fetal Disease in Mouse Model of Zika Infection, November 7, 2016
-
Skin Patch to Treat Peanut Allergy Shows Benefit in Children, October 26, 2016
For Researchers
NIAID partners with leaders in the fields of allergy, immunology, and transplantation research to better understand the associated diseases and conditions and move forward toward better prevention, diagnosis, and treatment.
NIAID and NIH offer a number of funding opportunities, including grants and contracts, to conduct basic research, preclinical development, or clinical evaluation.
Potential Funding Opportunities:
DAIT supports a comprehensive set of resources for researchers. Their purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent allergic, immunologic, or transplantation-related diseases and conditions.
Policies and procedures are essential to any clinical research enterprise. In this regard, the Division of Allergy, Immunology, and Transplantation has standardized and harmonized operational procedures across research areas.